Mirova’s NeoGenomics NEO Stock Holding History

Mirova’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-64,935	Closed	-$501K	–	105
2025 Q3	$501K	Hold	64,935	–	–	0.07%	91
2025 Q2	$475K	Hold	64,935	–	–	0.07%	98
2025 Q1	$616K	Hold	64,935	–	–	0.11%	88
2024 Q4	$1.07M	Buy	+64,935	New	+$1.01M	0.18%	75
2023 Q4	–	Sell	-36,731	Closed	-$452K	–	132
2023 Q3	$452K	Hold	36,731	–	–	0.09%	65
2023 Q2	$590K	Hold	36,731	–	–	0.1%	84
2023 Q1	$639K	Sell	36,731 -40,876	-53%	-$582K	0.09%	98
2022 Q4	$717K	Hold	77,607	–	–	0.11%	102
2022 Q3	$668K	Hold	77,607	–	–	0.11%	103
2022 Q2	$632K	Buy	77,607 +2,658	+4%	+$25.4K	0.09%	117
2022 Q1	$910K	Buy	74,949 +10,702	+17%	+$225K	0.12%	97
2021 Q4	$2.19M	Buy	64,247 +16,194	+34%	+$634K	0.26%	55
2021 Q3	$2.32M	Hold	48,053	–	–	0.3%	43
2021 Q2	$2.17M	Hold	48,053	–	–	0.26%	47
2021 Q1	$2.32M	Buy	48,053 +22,545	+88%	+$1.17M	0.28%	44
2020 Q4	$1.37M	Buy	+25,508	New	+$1.15M	0.18%	48

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Mirova's NEO Position: Q4 2025 in Review

Mirova sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 64,935 shares — an estimated $501K sold.

Mirova first reported a position in NEO in Q4 2020 and held it in 16 quarters. The position peaked at $2.32M in Q3 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

Mirova reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
Mirova sold 64,935 NeoGenomics shares in Q4 2025, an estimated $501K.
Mirova first reported a position in NeoGenomics in Q4 2020 and held it in 16 quarters.
Mirova's NeoGenomics position peaked at $2.32M in Q3 2021.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Mirova's 13F filing for Q4 2025, filed 13 Feb 2026.